Overview

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Status:
NOT_YET_RECRUITING

Trial end date:
2028-08-18

Target enrollment:

Participant gender:

Summary

A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.

Phase:

PHASE1

Details

Lead Sponsor:

Incyte Corporation